Hepatic hydrothorax (HH) is a pleural effusion that develops in a patient with cirrhosis and
portal hypertension in the absence of cardiopulmonary disease. Although the development …

Hepatic hydrothorax (HH) is an example of a porous diaphragm syndrome. Portal
hypertension results in the formation of ascitic fluid which moves across defects in the …

AIM: To assess the effectiveness of transjugular intrahepatic portosystemic stent shunt
(TIPSS) in refractory hepatic hydrothorax (RHH) in a systematic review and cumulative meta …

Purpose Case reports and small case series have reported a high rate of complications
associated with chest tube placement for hepatic hydrothorax. We describe the in-hospital …

Accumulation of fluid as ascites is the most common complication of cirrhosis. This is
occurring in about 50% of patients within 10 years of the diagnosis of cirrhosis. It is a …

PURPOSE: To evaluate safety and efficacy of transjugular intrahepatic portosystemic shunt
(TIPS) creation for hepatic hydrothorax (HHyd). MATERIALS AND METHODS: Twenty-one …

Background Hepatic hydrothorax (HH) is a serious complication of end-stage liver diseases,
which is associated with poor survival. There is no consensus regarding the treatment of HH …

Hepatopulmonary syndrome (HPS) and porto-pulmonary hypertension (PoPH) represent
relatively common pulmonary vascular complications of advanced liver disease. Despite …

Hepatic hydrothorax occurs in approximately 5 to12% of patients with cirrhosis and portal
hypertension. Various therapeutic modalities ranging from dietary and pharmacologic …

Objectives: Patients with cirrhosis can acquire pulmonary conditions that may or may not be
related to their illness. Although posing a greater risk for complications, chest tubes are …